Christopher Niyibizi
Photo
Academic title Associate professor of Orthopaedics and Rehabilitation
College College of Medicine
Campuses Penn State Milton S. Hershey Medical Center
Department Orthopaedics
Joint departments Biochemistry and Molecular Biology - HMC
Graduate programs Cell and Molecular Biology
Email Phone
  cniyibizi@psu.edu
  717 531 5649
 
Educational background
  MSc., Rutgers University, New Brunswick N.J., 1980
Ph.D., McGill University, Montreal Canada, 1985
Postdoctoral Training, Harvard Medical School, 1985-1986
Postdoctoral Training, University of Washington School of Medicine, Seattle WA, 1986-1989
Research interests
 

Skeletal Repair and Regeneration via stem cells

Our laboratory is interested in the biology of adult derived stem cells and their potential for skeletal repair and regeneration. The focus of the investigation is to understand engraftment characteristics of the cells and their fate when transplanted in vivo. The research uses animal models of skeletal diseases to explore the potential of stem cell therapy for the skeleton. The current focus is on a brittle bone disease that results from mutations in the genes that encode type I collagen a major structural protein of bone and other connective tissues. Patients with the brittle bone disease (osteogenesis imperfecta) exhibit frequent bone fractures and severe limb deformities). The mouse model of the disease used in the present study exhibits similar clinical features. The adult derived stem cells are isolated from the bone marrow, characterized by examining cell surface markers and differentiation into different cells phenotypes. Besides cell therapy investigations, gene transfer techniques using viral vectors carrying therapeutic genes are employed to deliver genes into the stem cells to investigate possible gene replacement in the patients? stem cells. Stem cells are tracked in vivo using imaging techniques and by examination of the differentiated cell phenotypes. Because most of the brittle bone disease mutations are dominant negative, the laboratory is also interested in inactivation of mutant genes in stem cells using various techniques, for example Ribozymes and SiRNAs.


Since the stem cells have the potential to differentiate into different cell lineages under appropriate conditions, the laboratory is also engaged in understanding the differentiation of the stem cells into chondrocytes, the cartilage cells. Gene transfer techniques are employed to deliver growth factor genes into stem cells for chondrocyte differentiation and cartilage formation in different matrices. The implication for this is that the cells can be used for cartilage repair and regeneration in case of trauma or osteoarthritis.

Areas of expertise
 
Gene TherapyOsteogenesis Imperfecta
Cartilage DiseasesCartilage, Articular
ChondrocytesMuscle, Skeletal
CollagenProcollagen
Bone Marrow CellsGenetic Vectors
RetroviridaeTransfection
Mesenchymal Stem Cell TransplantationBone Diseases
Adipose TissueCell Movement
Growth and DevelopmentMesenchymal Stem Cells
Publication author name
  Niyibizi C
Select publications
  Niyibizi C. Wang S. Mi Z. Robbins PD. Gene therapy approaches for osteogenesis imperfecta. 2004 Feb. Gene Ther. 11(4):408-16.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Adachi N. Sato K. Usas A. Fu FH. Ochi M. Han CW. Niyibizi C. Huard J. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. 2002 Sep. J Rheumatol. 29(9):1920-30.
Niyibizi C. Smith P. Mi Z. Phillips CL. Robbins P. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo. 2001 Jun 26-Jul 25. J Cell Biochem. 83(1):84-91.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute for Dental and Craniofacial Research
Oyama M. Tatlock A. Fukuta S. Kavalkovich K. Nishimura K. Johnstone B. Robbins PD. Evans CH. Niyibizi C. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. 1999 Mar. Gene Ther. 6(3):321-9.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Public Health Service

also ...
All publications